Accession Therapeutics Limited - Innovation in immunotherapy

Latest Press Release Announcing Momentum Pharma (BIA member organisation) growth, launching a business in Australia to better serve the Australia and APAC region.

Engitix announced the appointment of Sonia Quaratino, MD, PhD in the newly created role of Executive Vice President (EVP) Chief Medical Officer (CMO).

Analysis for Innovators (A4I) is a funding programme that helps UK SMEs overcome complex measurement, testing and analysis challenges by providing access to world-class expertise, specialist facilities and scientific knowledge from leading UK measurement organisations, including NML.

Coulter Partners, the global advisor building leadership teams for Health, Science and Technology innovation businesses, today announces the appointment of Carlos Gómez-Arnau, Doug Roberts, and Stuart Penney as Client Partners. These strategic hires further strengthen the firm's international presence and reinforce its commitment to supporting clients across key healthcare, life sciences, and biotechnology markets.

New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs

The NML has published its Annual Review 2025, reflecting on a year of scientific achievement, collaboration and investment in the future of UK chemical and biological measurement science. The Review showcases how the NML’s trusted measurement expertise is enabling innovation to be translated into real-world impact, supporting UK growth and regional expertise, and strengthening public confidence in policy and government decisions. If you would like to discuss any of the work featured in this Review or explore future collaboration opportunities with the NML, please contact [email protected]